Nagamani Vunnam

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Ankylosing Spondylitis

Gold Nanoparticles

Molecular Docking

Top Venues

ACS bio & med chem Au

Molecular pharmaceutics

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Elly E Liao, Mu Yang, Noah Nathan Kochen, Nagamani Vunnam, Anthony R Braun, David M Ferguson, Jonathan N Sachs
Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology. Molecular neurobiology (2023)
Nagamani Vunnam, Mu Yang, Chih Hung Lo, Carolyn N Paulson, William D Fiers, Evan Huber, MaryJane Been, David M Ferguson, Jonathan N Sachs
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling. ACS bio & med chem Au 3 (3) (2023)
Nagamani Vunnam, Mu Yang, Chih Hung Lo, Carolyn N Paulson, William D Fiers, Evan Huber, MaryJane Been, David M Ferguson, Jonathan N Sachs
Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling. ACS bio & med chem Au 3 (3) (2023)
Nagamani Vunnam, MaryJane Been, Evan Huber, Carolyn N Paulson, Sophia Szymonski, Benjamin J Hackel, Jonathan N Sachs
Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function. Molecular pharmaceutics (2023)